JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
  会員専用ページ

トップページ
学会案内
沿革
定款
役員・委員会
名誉会員・評議員
学術集会
総会学術集会
歴代総会・学術集会
支部・学術集会
学会教育研修会
国際関連学会
認定制度
リウマチ専門医
リウマチ指導医
教育施設
学会出版物
学会誌MR
NLリウマチ
リウマチ学用語集
会員手続き
本サイトについて
よくある質問
関連リンク集
サイトマップ
プライバシー

MODERN RHEUMATOLOGY Vol.14 No.4

>MR14-4

A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII
Takeo Sato1 , Kiyofumi Hagiwara1, Junnichi Chikazoe1, Yasunori Nakagawa2 and Osamu Akiyama1

(1) Department of Allergy and Rheumatology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan
(2) Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

Received: 04 September 2003 Accepted: 05 March 2004

Full Text
  > Click Here (member's only)

Abstract

We report the case of a patient who presented with acquired hemophilia associated with rheumatoid arthritis. The patient's factor VIII activity was less than 1% and factor VIII inhibitor was detected. Based on the blood analysis, the patient was diagnosed as having the factor VIII inhibitor. She was successfully treated with prednisolone, cyclophosphamide, and gammaglobulin to suppress the factor VIII inhibitor, and the administration of recombinant activated factor VII was effective in controlling severe bleeding episodes
 
Key words
Acquired hemophilia - Factor VIII - Intramuscular hemorrhage - Recombinant activated factor VII (rFVIIa) - Rheumatoid arthritis (RA)
 
一覧に戻る

Copyright Japan College of Rheumatology All rights reserved.